|

Heart Disease Clinical Trials in South Dakota

26 recruiting studies across 2 cities

All Trials in South Dakota

Phase
Trial Phase Location
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityPhase 3Rapid City
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFPhase 3Rapid City
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailurePhase 3Rapid City
Alleviant ALLAY-HF StudyN/ARapid City
Alleviant ALLAY-HFrEF StudyN/ARapid City
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic MaterialN/ARapid City
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPhase 3Rapid City
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 4Rapid City
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityPhase 3Rapid City
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsPhase 3Rapid City
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With AnticoagulationPhase 2Rapid City
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is UnsuitablePhase 3Rapid City
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPhase 3Rapid City
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionPhase 3Rapid City
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3Sioux Falls
Assessment of CCM in HF With Higher Ejection FractionN/ASioux Falls
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart FailureN/ASioux Falls
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry—Sioux Falls
NORM-HF Pivotal StudyN/ASioux Falls
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and IIIN/ASioux Falls
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)—Sioux Falls
Product Surveillance Registry—Sioux Falls
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford—Sioux Falls
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3Sioux Falls
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart FailureN/ASioux Falls
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRN/ASioux Falls

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.